Showing results (141-150 of 182) with videos related to
Sort By:
Pageof 19
Life Sciences|August 2, 2024
Intravenous injection of nattokinase-heparin electrostatic complex improves the therapeutic effect of advanced tumors by dissolving cancer-related thrombosisDazhi Wang, Yanmei Kou, Tiantian Guo, et al.Materials Today. Bio|February 21, 2024
Durable protective efficiency provide by mRNA vaccines require robust immune memory to antigens and weak immune memory to lipid nanoparticlesXueying Tang, Jiashuo Zhang, Dezhi Sui, et al.AAPS Pharmscitech|October 18, 2022
An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer MetastasisXianmin Meng, Mingqi Wang, Kaituo Zhang, et al.Molecular Imaging and Biology|August 23, 2006
Improved delivery in cell culture of radiolabeled antisense DNAs by duplex formationXinrong Liu, Kayoko Nakamura, Yi Wang, et al.Cancer Biology & Therapy|October 29, 2010
Identification of a high affinity TAG-72 binding peptide by phage display selectionNan Xiao, Dengfeng Cheng, Yi Wang, et al.Molecular Imaging and Biology|May 16, 2009
A convenient thiazole orange fluorescence assay for the evaluation of DNA duplex hybridization stabilityMinmin Liang, Xinrong Liu, Kayoko Nakamura, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 7, 2025
Host-pathogen hybrid glycocalyx mimicking lipid nanoparticles induce trained immunity as a promising platform for universal vaccinesXueying Tang, Yuejia Sun, Jiashuo Zhang, et al.Academic Radiology|April 10, 2026
The Rapid Long-axis Strain-based Prognostic Models Evaluate Composite Adverse Events for Asymptomatic Dextro-Transposition of the Great Arteries Patients after the Switch OperationLiwei Hu, Chen Guo, Xinrong Liu, et al.Molecular Pharmaceutics|November 16, 2022
Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor ImmunotherapyCong Li, Chuizhong Fan, Shuang Lu, et al.European Journal of Pharmacology|December 26, 2016
A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expressionZhenfei Bi, Wenrong Liu, Ruofang Ding, et al.Pageof 19